Critic at Large

Most Recent

image: Hard and Harder

Hard and Harder

By | June 5, 2011

The path to eradicating malaria in Africa involves much more than just a vaccine.

18 Comments

image: If Bacteria Can Do It…

If Bacteria Can Do It…

By | May 25, 2011

Learning community skills from microbes

0 Comments

image: Imagining a Cure

Imagining a Cure

By | April 11, 2011

For cancer patients, close is not good enough.

0 Comments

image: Another Revolution Needed?

Another Revolution Needed?

By | March 1, 2011

Counting the many plagues that threaten research in the Middle East and North Africa region

1 Comment

image: At the Tipping Point

At the Tipping Point

By | February 1, 2011

Data standards need to be introduced—now.

0 Comments

image: Garage Innovation

Garage Innovation

By | January 1, 2011

The potential costs of regulating synthetic biology must be counted against putative benefits.

0 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham